News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
117 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (21900)
Month
January (2433)
February (2866)
March (3029)
April (3115)
May (3356)
June (2725)
July (2286)
August (2090)
Day
1 (117)
2 (174)
3 (44)
5 (18)
6 (63)
7 (148)
8 (162)
9 (80)
10 (92)
12 (11)
13 (86)
14 (145)
15 (167)
16 (131)
17 (117)
19 (12)
20 (202)
21 (171)
22 (152)
23 (182)
24 (89)
26 (24)
27 (111)
28 (193)
29 (219)
30 (205)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
Day
1
2
3
5
6
7
8
9
10
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
IPO
UPDATE: Kailera breaks biotech IPO record with $625M debut
Obesity-focused Kailera Therapeutics debuted on the Nasdaq Friday after raising a record $625 million, beating Moderna’s $600 million from 2018.
April 17, 2026
·
4 min read
·
Tristan Manalac
Press Releases
Foundation Medicine to Strengthen Monitoring Portfolio with SAGA Diagnostics’ Tumor-Informed Molecular Residual Disease (MRD) Platform
April 17, 2026
·
5 min read
Press Releases
Promega to Showcase Oncology Research Tools and Companion Diagnostics at AACR Annual Meeting 2026
April 17, 2026
·
2 min read
Press Releases
Alkermes to Present Additional Data From Vibrance-1 Phase 2 Study of Alixorexton in Patients with Narcolepsy Type 1 at the American Academy of Neurology (AAN) 2026 Annual Meeting
April 17, 2026
·
10 min read
Press Releases
Delve Detect Enables Neurologists to Treat CNS Infections When Conventional Testing Fails
April 17, 2026
·
4 min read
Press Releases
Acerand Therapeutics Updates the Phase I/II Study of ACE-106 (ACE-86225106), a highly selective and Potentially Best-in-class PARP1 Inhibitor, in Advanced Solid Tumors
April 17, 2026
·
2 min read
Press Releases
Fulgent to Announce First Quarter 2026 Financial Results on Friday, May 1, 2026
April 17, 2026
·
1 min read
Press Releases
Organon To Report First Quarter 2026 Results and Host Conference Call on May 7, 2026
April 17, 2026
·
2 min read
Press Releases
Mirion Announces Earnings Release and Conference Call Date for First Quarter 2026
April 17, 2026
·
1 min read
Press Releases
Randomized Controlled Trial Published in Urogynecology Demonstrates Leva® Pelvic Health System’s Efficacy in Treating Fecal Incontinence
April 17, 2026
·
6 min read
1 of 12
Next
